Small G proteins as novel therapeutic targets in cardiovascular medicine

News in Physiological Sciences

Volumn 18, Issue 1, 2003, Pages 18-22

  Barandier, Christine ^a   Ming, Xiu Fen ^a   Yang, Zhihong ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; GTP BINDING PROTEINS; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RECOMBINANT INTERLEUKIN 1BETA;

ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG TARGETING; ENDOTHELIUM CELL; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHY; METABOLISM; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN TARGETING; RESTENOSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; VASOSPASM;

EID: 0037292463     PISSN: 08861714     EISSN: None     Source Type: Journal    
DOI: 10.1152/nips.01407.2002     Document Type: Article

References (17)

1. Clerk A and Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 86: 1019-1023, 2000.
2. Eto M, Barandier C, Rathgeb L, Kozai T, Joch H, Yang Z, and Luscher TF. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ Res 89: 583-590, 2001.
3. Evans M and Rees A. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same? Drug Saf 25: 649-663, 2002.
4. George J, Afek A, Keren P, Herz I, Goldberg I, Haklai R, Kloog Y, and Keren G. Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice. Circulation 105: 2416-2422, 2002.
5. Hargreaves IP and Heales S. Statins and myopathy. Lancet 359: 711-712, 2002.
6. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, and Lamas S. Effects of the 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719, 1998.
7. Kip degradation through its regulation of cyclin E/CDK2 activity. J Biol Chem 274: 3396-3401, 1999.
8. Lamping KG. Enhanced contractile mechanisms in vasospasm: is endothelial dysfunction the whole story? Circulation 105: 1520-1522, 2002.
9. Matozaki T, Nakanishi H, and Takai Y. Small G-protein networks: their crosstalk and signal cascades. Cell Signal 12: 515-524, 2000.
10. Morishige K, Shimokawa H, Eto Y, Hoshijima M, Kaibuchi K, and Takeshita A. In vivo gene transfer of dominant-negative rho-kinase induces regression of coronary arteriosclerosis in pigs. Ann NY Acad Sci 947: 407-411, 2001.
11. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, and Brown JH. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 89: 488-495, 2001.
12. Somlyo AP and Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185, 2000.
13. Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 346: 539-540, 2002.
14. Takemoto M and Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 21: 1712-1719, 2001.
15. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
16. Work LM, McPhaden AR, Pyne NJ, Pyne S, Wadsworth RM, and Wainwright CL. Short-term local delivery of an inhibitor of Ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty. Circulation 104: 1538-1543, 2001.
17. Yang Z, Kozai T, van der Loo B, Viswambharan H, Lachat M, Turina MI, Malinski T, and Luscher TF. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. J Am Coll Cardiol 36: 1691-1697, 2000.